Research output per year
Research output per year
Fingerprint
Dive into the research topics where Grace Holt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
- 1 Article
-
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial
Innovative Therapies for Children with Cancer (ITCC) Consortium & European Association for Neuroblastoma Research (SIOPEN), 8 Jan 2024, (E-pub ahead of print) In: Journal of Clinical Oncology.Research output: Contribution to journal › Article › peer-review
Open AccessFile55 Downloads (Pure)
Projects
- 2 Active
-
Glo-BNHL: Regeneron Collaboration - A Global Study Of Novel Agents In Relapsed And Refractory B-Non Hodgkin Lymphoma (B-NHL)
Kearns, P. (Co-Investigator), Billingham, L. (Principal Investigator), Maycock, S. (Researcher), Holt, G. (Co-Investigator) & Siddique, S. (Co-Investigator)
1/07/23 → 30/06/28
Project: Industry
-
Global Study of Novel Agents in relapsed and refractory B-NHL with ADCT
Billingham, L. (Researcher), Kearns, P. (Researcher), Siddique, S. (Principal Investigator) & Holt, G. (Researcher)
1/08/21 → 31/01/28
Project: Industry